Does HEA must eat with Coenzyme Q10? Do you need to take DHEAMH for pregnancy?

Home > Baby

Does HEA must eat with Coenzyme Q10? Do you need to take DHEAMH for pregnancy?

2021-11-28 18:06:28 51 ℃

DHEA Coenzyme Q10 ovarian premature aging, can DHEAAMH really improve ovarian function? DHEA Coenzyme Q10 ovarian decades, can DHEAAMH really improve the ovarian function? DHEA Co10 conditioning ovarian premature aging?

We first analyze the DHEA and Coenzyme Q10 from the aspect. The main role of coenzyme Q10 is antioxidant, and its antioxidant capacity is 40 times the vitamin E. Coenzyme Q 10 can improve the ovarian function after 1-2 months, and there is a certain assistive role. Therefore, the coenzyme Q10 can be supplemented in the elderly population to improve the Egg's ATP energy, improve the pregnancy ending. (DHEA Coenzyme Q10 ovarian premature aging, can DHEAAMH really improve ovarian function?)

The ingredients of DHEA are vitamin C, vitamin D, vitamin B1, vitamin B2, vitamin B3, folic acid, vitamin B12, zinc, selenium, chromium other mixed vitamins, arginine, L-carnitine, acetyl left carnitine, taurine , Coenzyme Q10, acetylcysteine, lycopene, citric acid, 叱 喹 喹, pine bark extract, and the like. If you only look at the ingredients, these are not strict. Although DHEA can have a certain role in ovarian, it maintains two attitudes for its safety. The US Department of Endoclochemistry is jointly studied by DHEA derivative factor DHEAAMH to develop DHEA derivative factors (ESE) and IMMs (IMS). Then the quality of DHEAMH's quality certification can be used.

1. Quality management system: "At the same time" through ISO9001, HACCP, European Drug Quality Administration EDQM quality system certification, "US FDA Food Safety Modernization Act", Norwegian Classification Agency, European Food Registration, French Safety and Control, EFSA European Food Safety Agency's Health Certification, Australian Treatment Supplies Authority.

2. Production Process Management System: DHEAMH does not adopt genetic engineering and its products, do not use chemical synthetic pesticides, fertilizers, growth regulators, feed additives, etc. , Atmospheric monitoring, production site environmental testing, also conduct inspections of raw materials, producing, processing, processing, every link is extremely stringent in terms of standard requirements.

3, content management system: DHEAMH content 13g bag, all batch samples should be net weight identification, the weight difference indicated by the weight and label should not exceed ± 1%, and the sealing packaging should be tested.

4, efficiency management system: The experimenter has improved in sleep, ovarian, blood supply, follicles, "North American Clinical Properties Science and Women" gives DHEAAMH for ovarian early ovaries in 43 cases of fertility, and the results Serum hormone levels have improved, and estrogen has increased, serum LH and FSH have declined slightly, and 38 people in 43 people have menstrual cramps, and the symptoms and signs of the periphement have improved.

5, packaging management: The outer packaging must be printed with DHEAAMH. 6. Safety management system: production process, raw material collection, DIN World Pharmaceutical Safety Standard Fundamental System: The product produced by the company has the effect of drugs, but there is no drug to poisonous role.

7, raw material management system: Improving the management of raw materials in two countries is more rigorous and safe, and belongs to European international certification standards. 8. Multi-country supervision and management system: "The FDA Food Safety Modernization Act", France "European Law" EU food supplement management related regulations. (DHEA Coenzyme Q10 ovarian premature aging, can DHEAAMH really improve ovarian function?)

Can DHEAAMH really improve ovarian function? Studies have shown that DHEAAMH can increase the expression of particulate cell proliferation markers and the level of sinus follicles and early ethobularization period, promote follicular production, increase the number of eggs and oocytes.

The adhesion protein is a composition ingredient of the extracellular matrix to some extent, to a certain extent, to reflect the function of the cells. DHEAAMH may increase the number of follicles of older women by inhibiting follicular apoptosis and slowing the rate of adhesion protein levels.

DHEAMH Clinical Results 1. Improved ovulation Periods Alone or with other hormones using DHEAAMH will increase women's response to promoting ovulation, and DHEAAMH may be an auxiliary means of ovulation in oocytes and embryos. Oral DHEAAMH is at least about 1 month, preferably for about 4 months, preferably for about 4 months, and can stimulate the ovary of the gonadotropin. By joint treatment of gonadotropin and DHEAAMH for at least four months prior to the test tube cycle, a large reaction can be obtained.

2. Improvement of cumulative embryonic assessment DHEAMH uses beneficially affects oocytes and embryonic quality. DHEAAMH and the observations related to improving cumulative embryonic review show that this treatment can improve embryonic and egg quality. This proposal has been further supported by improving embryo interpolation and improving pregnancy rates. DHEAAMH includes a dose of about 13 g / days to about 26 g / day, DHEAAMH treatment can apply to DHEAAMH for ovarian function. DHEAMH is a significant effect on cumulative embryonic assessment after approximately 2 months. The role can continue to increase until about 4 months, or about 16 weeks, and further use more than four months. Female cumulative embryo review prior to using DHEAMH may be about 34. Cumulative embryo reviews after using DHEAAMH for at least four months can be at least about 90, and the increase in cumulative embryonic assessment can be at least about 64. Cumulative embryonic assessment before DHEAMH is statistically significant, P (DHEA Coenzyme Q10 ovarian, eating DHEAAMH really improves ovarian function?)

3, increasing the number of affinity edible oocytes DHEAMH has significantly increased the number of fertilized oocytes produced by women. DHEAAMH Therapy includes approximately 13 g / days to about 26 g / day for human women, and DHEAMH may have an effect on the number of fertilized oocytes after 4 weeks. However, DHEAMH has a significant effect on the number of hostess edible oocytes for about 8 weeks or 2 months, and its effect may continue to increase for about four months, and further may continue to use more than four months. Specifically, in 12 women, after the treatment of DHEAAMH, the number of fertilized oocytes produced by women increased significantly, although it showed a slight improvement after the continuous DHEAMH used for at least 4 weeks, from DHEAMH Feminic oocytes with less than about 4 weeks and DHEAMH with DHEAMH for 4 weeks of the same female feeding oocytes, a pair of fertilized oocytes, showing about 2 affinity edible oocytes, or about 2.5 fertilized eggs Medium value increases oocytes. The number of affailed oocytes may exhibit more significant increases after DHEAAMH treatment at least about 4 months, and may exhibit a maximum increase in DHEAAMH treatment at least about eight months.

4, neutral increasing ovarian reserves reduce the number of eggs of women and the number of embryo transplants. The use of DHEAAMH pretreatment at least about 1 month, preferably at least about 4 months, can increase oocytes and embryos, eggs and embryo quality, accumulated pregnancy rate, test tube pregnancy and pregnancy. (DHEA Coenzyme Q10 ovarian premature aging, can DHEAAMH really improve ovarian function?)